Komori
Image Information (3803) · FactCited as achieved

Deconsolidation Through the Transfer of All Shares in 株式会社マーベラント

First written in FY2022-Q2. 4 of 5 entries say "Cited as achieved", first in FY2022-Q3. Latest entry: FY2023-Q3.

5entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseCited as achievedFY2022-Q2 – FY2023-Q32021: 120212022: 320222023: 12023
Same theme, other companies
Removal from the Scope of Consolidation Through the Transfer of Shares in a SubsidiaryA theme 314 companies write about · 44 as a headwind · 223 as a tailwind

25 other companies' latest entry also says "Cited as achieved".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 156 companies compared. The sentences above are computed from all 156.Comparing 200 of the theme's 397 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2023-Q3Cited as achievedAnnual report

    「As all shares of 株式会社マーベラント, the operating company of the medical and anti-aging business, were transferred in the previous consolidated fiscal year, this segment recorded no revenue for the first nine months of the current consolidated fiscal year.」

    The transfer of all shares in マーベラント and its exclusion from consolidation are reiterated as completed facts underlying the absence of revenue from the Other segment.
  2. FY2023-Q2Cited as achievedAnnual report

    「Following the transfer of all shares in 株式会社マーベラント, the operating company of the Medical & Anti-Aging business during the previous consolidated fiscal year, the segment had no revenue during the six months ended the second quarter of the current consolidated fiscal year.」

    The filing continues to state that the Other segment has no revenue following the transfer of all shares in マーベラント and its exclusion from consolidation.
  3. FY2023-Q1Cited as achievedAnnual report

    「Through the transfer of all shares in 株式会社マーベラント, the operating company of the Medical & Anti-Aging business, during the previous consolidated fiscal year」

    The transfer of all shares in マーベラント and its exclusion from consolidation are reiterated as the background to the disappearance of revenue from the Other segment.
  4. FY2022-Q3Cited as achievedAnnual report

    「We transferred all shares in 株式会社マーベラント, a consolidated subsidiary, to 株式会社ホーイズム on 28 September 2021. As of 31 December 2021, our group consisted of the holding company and 1 consolidated subsidiary.」

    The filing reconfirms the transfer of all shares in 株式会社マーベラント and its exclusion from consolidation, stating that the group consisted of the company and 1 consolidated subsidiary at the end of the quarter.
  5. FY2022-Q2First statedAnnual report

    「Subsequently, as the share transfer procedures were completed on 28 September 2021, 株式会社マーベラント was excluded from the scope of consolidation.」

    The filing first states that the transfer of all shares in 株式会社マーベラント, formerly a consolidated subsidiary, was completed on 28 September 2021 and that the company was excluded from the scope of consolidation.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Image Information yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.